These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6948755)

  • 1. Subacute and chronic myelomonocytic leukemia.
    Zittoun R
    Haematol Blood Transfus; 1981; 27():157-65. PubMed ID: 6948755
    [No Abstract]   [Full Text] [Related]  

  • 2. [Muramidase (lysozyme) in differential diagnosis of acute leukemia].
    Burchardt K; Wysocki H; Wierusz B; Prazmowska B
    Acta Haematol Pol; 1974; 5(2):119-25. PubMed ID: 4525400
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical conference: Transcobalamins and lysozyme in various evolving stages of chronic myeloid leukemia].
    Zittoun J; Zittoun R; Marquet J; Sultan C
    Nouv Rev Fr Hematol; 1975; 15(2):289-97. PubMed ID: 126440
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow cell kinetics and culture in chronic and subacute myelomonocytic leukemia. Physiopathological interpretation and prognostic importance.
    Dresch C; Faille A; Poirier O; Balitrand N; Najean Y
    Leuk Res; 1980; 4(1):129-42. PubMed ID: 6931951
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute myelogenous leukaemia of adults: diagnosis, prognosis and treatment (author's transl)].
    Abbrederis K; Michlmayr G; Schmalzl F; Huber H; Braunsteiner H
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1743-7. PubMed ID: 4517776
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum and urine muramidase activity in acute and chronic leukemia].
    Senn HJ; Rhomberg WU
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1993-5. PubMed ID: 5279363
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelomonocytic leukemia: clinical, cytological, and cytogenetic studies of acute, subacute, and chronic forms (author's transl)].
    Mende S; Fülle HH; Knuth A; Weissenfels I
    Blut; 1977 Jul; 35(1):21-34. PubMed ID: 268223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preleukemia and "smoldering" leukemia as a clinical and research problem].
    Zduńczyk A; Blicharski J; Skotnicki AB
    Pol Arch Med Wewn; 1982 Oct; 68(4):259-67. PubMed ID: 6763690
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical-haematological aspects of subacute myelomonocytic leukaemia: a study of seven cases (author's transl)].
    Chelazzi G; Dozio F; Piccinelli O; Rossi D
    Sangre (Barc); 1981; 26(3):300-8. PubMed ID: 6945741
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases.
    Solal-Celigny P; Desaint B; Herrera A; Chastang C; Amar M; Vroclans M; Brousse N; Mancilla F; Renoux M; Bernard JF
    Blood; 1984 Mar; 63(3):634-8. PubMed ID: 6582939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital monocytic leukaemia.
    Lilleyman JS
    Clin Lab Haematol; 1980; 2(3):243-5. PubMed ID: 6933032
    [No Abstract]   [Full Text] [Related]  

  • 12. Extramedullary myeloblastic transformation of chronic myelocytic leukemia. Lymph node infiltration one year before marrow blastic change.
    Woodson DL; Bennett DE; Sears DA
    Arch Intern Med; 1974 Sep; 134(3):523-6. PubMed ID: 4527801
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic value of muramidase.
    Davis CS
    Postgrad Med; 1971 Apr; 49(4):51-4. PubMed ID: 4994644
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma muramidase: a study of methods and clinical applications.
    Zucker S; Hanes DJ; Vogler WR; Eanes RZ
    J Lab Clin Med; 1970 Jan; 75(1):83-92. PubMed ID: 5262383
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic value of muramidase (Lysozyme) in acute leukemia and preleukemia.
    Youman JD; Saarni MI; Linman JW
    Mayo Clin Proc; 1970 Mar; 45(3):219-28. PubMed ID: 5265483
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic myelomonocytic leukemia (CMMoL) and chronic monocytic leukemia (CMoL)--with special reference to their difference, therapy and blastic crisis].
    Hirayama F; Ishihara K; Soma T; Kojima K; Kubota Y; Teshima H; Ueda T; Tsubakio T; Nakamura H; Shibata H
    Rinsho Ketsueki; 1985 Oct; 26(10):1621-8. PubMed ID: 3867762
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders.
    Rachmilewitz B; Rachmilewitz M
    Isr J Med Sci; 1977 Jul; 13(7):710-5. PubMed ID: 270474
    [No Abstract]   [Full Text] [Related]  

  • 18. Marrow culture studies in the myeloid leukemias.
    Clin Bull; 1974; 4(4):164-6. PubMed ID: 4533588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of muramidase (lysozyme) using an indirect cytochemical (cytobacterial) technic. Its significance in the differential diagnosis of hemoblastoses].
    Natoneková K; Szabó J; Béresová RM; Ruthnerová MO; Hollánová SR
    Vnitr Lek; 1977 Sep; 23(9):893-900. PubMed ID: 270252
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myelodysplastic syndromes].
    Rupniewska ZM; Kurowska M
    Pol Arch Med Wewn; 1983 Oct; 70(4):179-87. PubMed ID: 6582447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.